Table III.
Individuals n | Diag-noses | MM | AK | SCC | BCC | Vasc | Lentigo | Nevus | SK | DF | Other | Referred individuals | Teledermato-logical referrals | MM days to manage-ment (mean)a | Dermato-scope used | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PreT cohort | ||||||||||||||||
Unit 1 | 205 | 243 | 8 | 34 | 7 | 18 | 10 | 3 | 67 | 79 | 5 | 12 | 82 | 0 | 63,4 | 33 |
Unit 2 | 378 | 465 | 7 | 41 | 14 | 42 | 12 | 2 | 124 | 156 | 13 | 53 | 103 | 0 | 60,3 | 250 |
Unit 3 | 570 | 689 | 12 | 67 | 12 | 32 | 31 | 2 | 308 | 197 | 7 | 21 | 136 | 0 | 46,4 | 298 |
Total | 1,153 | 1,397 | 28 | 142 | 33 | 92 | 53 | 7 | 499 | 432 | 25 | 86 | 321 | 0 | 581 | |
PostT cohort | ||||||||||||||||
Unit 1 | 183 | 221 | 3 | 24 | 4 | 10 | 10 | 6 | 48 | 96 | 8 | 12 | 68 | 54 | 20.7 | 92 |
Unit 2 | 333 | 391 | 5 | 62 | 13 | 39 | 9 | 1 | 89 | 114 | 11 | 48 | 113 | 61 | 40,4 | 221 |
Unit 3 | 468 | 564 | 8 | 57 | 13 | 45 | 18 | 3 | 202 | 190 | 8 | 20 | 140 | 96 | 66,4 | 313 |
Total | 984 | 1,176 | 16 | 143 | 30 | 94 | 37 | 10 | 339 | 400 | 27 | 80 | 321 | 211 | 626 |
Counted from day of referral.
Vasc: vascular lesion; SK: seborrheic keratosis; DF: dermatofibroma; MM: malignant melanoma; AK: actinic keratosis; SCC: squamous cell carcinoma; BCC: basal cell carcinoma.